A trial of the effect of probiotics on the development of atopy and eczema in children
University of Otago
510 participants
Jan 21, 2004
Interventional
Conditions
Summary
Probiotics (found in fermented foods) when given to infants may exert a protective effect on the development of allergy by influencing the developing immune system. This study aims to determine whether dietary supplementation in infants with 2 different probiotics results in differences in atopy and eczema prevalence at age 2 years.
Eligibility
Inclusion Criteria2
- a) Pregnant women at least 37 weeks gestation
- b) Pregnant women where they or their partner has a history of asthma, hay fever of eczema treated by a doctor.
Exclusion Criteria7
- a) Planning to move from study centres during study period
- b) Birth weight lower than the 3rd percentile for gender and gestation
- c) Infant admission to neonatal unit for at least 48 hours
- d) Serious congenital abnormalities
- e) Long-term probiotic use in mother
- f) Mother intends to give probiotics to child if they develop eczema
- g) Mother has taken less than 2 weeks study probiotics during pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Study interventions were the probiotics, Lactobacillus rhamnosus (10**9 colony forming units) and Bifidobacteria lactis (10**9 colony forming units) administered orally. In mothers this was taken daily from 35 weeks gestation till 6 months if breastfeeding. In infants this was administered daily from birth for 2 years.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000518460